Austin G. Stack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Austin G. Stack has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alan Hanley
Regional Kidney Center Letterkenny and Sligo General Hospitals, Health Services Executive West Donegal Ireland
1 shared publicationAmir Mohammed
Regional Kidney Center Letterkenny and Sligo General Hospitals, Health Services Executive West Donegal Ireland
1 shared publicationArif Mutwali
Regional Kidney Center Letterkenny and Sligo General Hospitals, Health Services Executive West Donegal Ireland
1 shared publicationBhamidipati Murthy
1 shared publicationBhamidipati V.R. Murthy
Division of Renal Disease and Hypertension, Department of Internal Medicine, University of Texas Medical School, Houston, Texas
1 shared publicationHoang Nguyen
‡ Lifestat Corporation Houston Texas
1 shared publication
Latest Publications
- Open Access
- 1 August 2011
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 6 (8) , 1982-1989
Survival Trends of US Dialysis Patients with Heart Failure
Summary: Background and objectives: Congestive heart failure (CHF) is a major risk factor for death in end-stage kidney disease; however, data on prevalence and survival trends are limited. The objective of this study was to determine the prevalence and mortality effect of CHF in successive incident dialysis cohorts. Design, setting, participants, & measurements: This was a population-based cohort of incident US dialysis patients (n = 926,298) from 1995 to 2005. Age- and gender-specific prevalence of CHF was determined by incident year, whereas temporal trends in mortality were compared using multivariable Cox regression. Results: The prevalence of CHF was significantly higher in women than men and in older than younger patients, but it did not change over time in men (range 28% to 33%) or women (range 33% to 36%). From 1995 to 2005, incident death rates decreased for younger men (≤70 years) and increased for older men (>70 years). For women, the pattern was similar but less impressive. During this period, the adjusted mortality risks (relative risk [RR]) from CHF decreased in men (from RR = 1.06 95% Confidence intervals (CI) 1.02–1.11 in 1995 to 0.91 95% CI 0.87–0.96 in 2005) and women (from RR = 1.06 95% CI 1.01–1.10 in 1995 to 0.90 95% CI 0.85–0.95 in 2005 compared with referent year 2000; RR = 1.00). The reduction in mortality over time was greater for younger than older patients (20% to 30% versus 5% to 10% decrease per decade). Conclusions: Although CHF remains a common condition at dialysis initiation, mortality risks in US patients have declined from 1995 to 2005.
- 1 August 2011
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 6 (8) , 1982-1989
Open AccessSurvival Trends of US Dialysis Patients with Heart Failure
Summary: Background and objectives: Congestive heart failure (CHF) is a major risk factor for death in end-stage kidney disease; however, data on prevalence and survival trends are limited. The objective of this study was to determine the prevalence and mortality effect of CHF in successive incident dialysis cohorts. Design, setting, participants, & measurements: This was a population-based cohort of incident US dialysis patients (n = 926,298) from 1995 to 2005. Age- and gender-specific prevalence of CHF was determined by incident year, whereas temporal trends in mortality were compared using multivariable Cox regression. Results: The prevalence of CHF was significantly higher in women than men and in older than younger patients, but it did not change over time in men (range 28% to 33%) or women (range 33% to 36%). From 1995 to 2005, incident death rates decreased for younger men (≤70 years) and increased for older men (>70 years). For women, the pattern was similar but less impressive. During this period, the adjusted mortality risks (relative risk [RR]) from CHF decreased in men (from RR = 1.06 95% Confidence intervals (CI) 1.02–1.11 in 1995 to 0.91 95% CI 0.87–0.96 in 2005) and women (from RR = 1.06 95% CI 1.01–1.10 in 1995 to 0.90 95% CI 0.85–0.95 in 2005 compared with referent year 2000; RR = 1.00). The reduction in mortality over time was greater for younger than older patients (20% to 30% versus 5% to 10% decrease per decade). Conclusions: Although CHF remains a common condition at dialysis initiation, mortality risks in US patients have declined from 1995 to 2005.
- 10 May 2010
- Published by Wiley in Seminars in Dialysis
- Vol. 23 (3) , 298-305
Cigarette Use and Cardiovascular Risk in Chronic Kidney Disease: An Unappreciated Modifiable Lifestyle Risk Factor
Tobacco use is a major modifiable cardiovascular risk factor in the general population and contributes to excess cardiovascular risk. Emerging evidence from large-scale observational studies suggests that continued tobacco use is also an independent cardiovascular risk factor among patients with chronic kidney disease (CKD). The benefits of smoking cessation programs on improving the heath status of patients and reducing mortality are unequivocal in the general population. Despite this, there has been little effort in pursuing tobacco cessation programs in dialysis cohorts or those with lesser degrees of kidney impairment. Most of our attention to date has focused on the development of "kidney-specific" interventions that reduce rates of renal disease progression and improve dialysis outcomes. The purpose of this current review is to describe the epidemiology of tobacco use among patients with CKD, draw attention to its negative impact on cardiovascular morbidity and mortality, and finally highlight potential strategies for successful intervention. We hope that this study heightens the importance of tobacco use in CKD, stimulates renewed interest in the barriers and challenges that exist in achieving smoking cessation, and endorses the efficacy of intervention strategies and the immeasurable benefits of quitting on cardiovascular and noncardiovascular outcomes.
- 10 May 2010
- Published by Wiley in Seminars in Dialysis
- Vol. 23 (3) , 298-305
Cigarette Use and Cardiovascular Risk in Chronic Kidney Disease: An Unappreciated Modifiable Lifestyle Risk Factor
Tobacco use is a major modifiable cardiovascular risk factor in the general population and contributes to excess cardiovascular risk. Emerging evidence from large-scale observational studies suggests that continued tobacco use is also an independent cardiovascular risk factor among patients with chronic kidney disease (CKD). The benefits of smoking cessation programs on improving the heath status of patients and reducing mortality are unequivocal in the general population. Despite this, there has been little effort in pursuing tobacco cessation programs in dialysis cohorts or those with lesser degrees of kidney impairment. Most of our attention to date has focused on the development of "kidney-specific" interventions that reduce rates of renal disease progression and improve dialysis outcomes. The purpose of this current review is to describe the epidemiology of tobacco use among patients with CKD, draw attention to its negative impact on cardiovascular morbidity and mortality, and finally highlight potential strategies for successful intervention. We hope that this study heightens the importance of tobacco use in CKD, stimulates renewed interest in the barriers and challenges that exist in achieving smoking cessation, and endorses the efficacy of intervention strategies and the immeasurable benefits of quitting on cardiovascular and noncardiovascular outcomes.
- 1 December 2008
- Published by Elsevier in Annals of Epidemiology
- Vol. 18 (12) , 880-888
Exercise and Limitations in Physical Activity Levels among New Dialysis Patients in the United States: An Epidemiologic Study
- 1 December 2008
- Published by Elsevier in Annals of Epidemiology
- Vol. 18 (12) , 880-888
Exercise and Limitations in Physical Activity Levels among New Dialysis Patients in the United States: An Epidemiologic Study